ArticleHepatology (Baltimore, Md.)2017
The underreporting of hepatocellular carcinoma to the cancer register and a log-linear model to estimate a more correct incidence.
Article in Hepatology (Baltimore, Md.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Completeness Evaluation of Adult-Population-Based Cancer Registries: A Systematic Review.Cancers · 2025Review
- Long-term risk of chronic liver disease in patients with celiac disease: a nationwide population-based, sibling-controlled cohort study.The Lancet regional health. Europe · 2025Article
- Temporal patterns of cancer burden in Asia, 1990-2019: a systematic examination for the Global Burden of Disease 2019 study.The Lancet regional health. Southeast Asia · 2024Article
- Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019.European journal of epidemiology · 2023Observational
- Chronic hepatitis B virus infection and the risk of hepatocellular carcinoma by age and country of origin in people living in Sweden: A national register study.Hepatology communications · 2022Article
- Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals.Journal of internal medicine · 2022Article
- The risk of hepatocellular carcinoma in cirrhosis differs by etiology, age and sex: A Swedish nationwide population-based cohort study.United European gastroenterology journal · 2022Article
- Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.United European gastroenterology journal · 2022Article
- Cancer Risk in Patients With Autoimmune Hepatitis: A Nationwide Population-Based Cohort Study With Histopathology.American journal of epidemiology · 2022Article
- Robotic-Assisted Surgery for Primary Hepatobiliary Tumors-Possibilities and Limitations.Cancers · 2022Review
- Cancer Risk in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.Hepatology (Baltimore, Md.) · 2021Article
- Estimating regional prevalence of chronic hepatitis C with a capture-recapture analysis.BMC infectious diseases · 2021Article
- Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality.The New England journal of medicine · 2020Article
- Characterization of liver nodules in patients with chronic liver disease by MRI: performance of the Liver Imaging Reporting and Data System (LI-RADS v.2018) scale and its comparison with the Likert scale.La Radiologia medica · 2020Article
- Central nervous system tumor registration in the Swedish Cancer Register and Inpatient Register between 1990 and 2014.Clinical epidemiology · 2019Article
- Hepatic resection for primary and secondary liver malignancies.Innovative surgical sciences · 2017Review
- Liver-related morbidity and mortality in patients with chronic hepatitis C and cirrhosis with and without sustained virologic response.Clinical epidemiology · 2017Article
- Article
Corrections and comments
- Commented on by
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Cancer Register (CR) in Sweden has reported that the incidence of primary liver cancer (PLC) has slowly declined over the last decades. Even though all cancers, irrespective of diagnostic method, should be reported to the CR, the PLC incidence may not reflect the true rate. Improved diagnostic tools have enabled diagnosis of hepatocellular carcinoma based on noninvasive methods without histological verification, possibly associated with missed cancer reports or misclassification in the CR. Our objective was to study the completeness and assess the underreporting of PLC to the CR and to produce a more accurate estimate based on three registers. The CR, the Cause of Death Register, and the Patient Register were investigated. Differences and overlap were examined, the incidence was estimated by merging data from the registers, and the number reported to none of the registers was estimated using a log-linear capture-recapture model. The results show that 98% of the PLCs reported to the CR were histologically verified; 80% were hepatocellular carcinoma and 20% were intrahepatic cholangiocarcinoma. Unspecified liver cancer decreased over time and constituted <10% of all reported liver cancers. The CR may underestimate the liver cancer incidence by 37%-45%, primarily due to missed cancer reports. The estimated annual number of liver cancers increased over time, but the standardized incidence was stable around 11 per 100,000. Hepatitis C-associated liver cancer increased and constituted 20% in 2010.
conclusionThere was an underreporting of PLC diagnosed by noninvasive methods; the incidence was considerably higher than estimated by the CR, with a stable incidence over time; reporting needs to improve and combining registers is recommended when studying incidence. (Hepatology 2017;65:885-892).
Indexed as
Identifiers
27533761What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.